Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mu Sun

Showing results (311-320 of 338) with videos related to

Pageof 34
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 19, 2025
Perioperative Pembrolizumab for Locally Advanced Thymic Epithelial Tumors: A Single-Arm, Phase 2 TrialYeong Hak Bang, Jae Myoung Noh, Boram Lee, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 5, 2015
Phase II trial of epidermal growth factor ointment for patients with Erlotinib-related skin effectsIn Gyu Hwang, Jung Hun Kang, Sung Yong Oh, et al.
Journal for Immunotherapy of Cancer|October 20, 2020
Clinical advantage of targeted sequencing for unbiased tumor mutational burden estimation in samples with low tumor purityTae Hee Hong, Hongui Cha, Joon Ho Shim, et al.
Ebiomedicine|March 16, 2024
Comprehensive analysis of transcription factor-based molecular subtypes and their correlation to clinical outcomes in small-cell lung cancerSehhoon Park, Tae Hee Hong, Soohyun Hwang, et al.
World Journal of Gastroenterology|April 21, 2015
Weekly docetaxel and gemcitabine in previously treated metastatic esophageal squamous cell carcinomaMin-Young Lee, Ki Sun Jung, Hae Su Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2022
Clinical, Pathologic, and Molecular Prognostic Factors in Patients with Early-Stage EGFR-Mutant NSCLCHyun Ae Jung, Jinyeong Lim, Yoon-La Choi, et al.
Cancer Immunology, Immunotherapy : CII|October 9, 2024
Biomarker role of thyroid irAE and PD-L1 positivity in predicting PD-1 blockade efficacy in patients with non-small cell lung cancerHye In Kim, Won Gu Kim, Mijin Kim, et al.
Lancet (London, England)|August 29, 2021
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 studyJong-Mu Sun, Lin Shen, Manish A Shah, et al.
Eclinicalmedicine|June 17, 2025
Adjuvant pembrolizumab therapy for completely resected stage I lung adenocarcinoma with micropapillary or solid histological subtypes: a single-center, single-arm, phase 2 trialJhingook Kim, Yeong Hak Bang, Sehhoon Park, et al.
Nature Communications|May 10, 2020
Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinomaNayoung Kim, Hong Kwan Kim, Kyungjong Lee, et al.
Pageof 34

Showing results (311-320 of 338) with videos related to

Sort By:
Pageof 34
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 19, 2025
Perioperative Pembrolizumab for Locally Advanced Thymic Epithelial Tumors: A Single-Arm, Phase 2 TrialYeong Hak Bang, Jae Myoung Noh, Boram Lee, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 5, 2015
Phase II trial of epidermal growth factor ointment for patients with Erlotinib-related skin effectsIn Gyu Hwang, Jung Hun Kang, Sung Yong Oh, et al.
Journal for Immunotherapy of Cancer|October 20, 2020
Clinical advantage of targeted sequencing for unbiased tumor mutational burden estimation in samples with low tumor purityTae Hee Hong, Hongui Cha, Joon Ho Shim, et al.
Ebiomedicine|March 16, 2024
Comprehensive analysis of transcription factor-based molecular subtypes and their correlation to clinical outcomes in small-cell lung cancerSehhoon Park, Tae Hee Hong, Soohyun Hwang, et al.
World Journal of Gastroenterology|April 21, 2015
Weekly docetaxel and gemcitabine in previously treated metastatic esophageal squamous cell carcinomaMin-Young Lee, Ki Sun Jung, Hae Su Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2022
Clinical, Pathologic, and Molecular Prognostic Factors in Patients with Early-Stage EGFR-Mutant NSCLCHyun Ae Jung, Jinyeong Lim, Yoon-La Choi, et al.
Cancer Immunology, Immunotherapy : CII|October 9, 2024
Biomarker role of thyroid irAE and PD-L1 positivity in predicting PD-1 blockade efficacy in patients with non-small cell lung cancerHye In Kim, Won Gu Kim, Mijin Kim, et al.
Lancet (London, England)|August 29, 2021
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 studyJong-Mu Sun, Lin Shen, Manish A Shah, et al.
Eclinicalmedicine|June 17, 2025
Adjuvant pembrolizumab therapy for completely resected stage I lung adenocarcinoma with micropapillary or solid histological subtypes: a single-center, single-arm, phase 2 trialJhingook Kim, Yeong Hak Bang, Sehhoon Park, et al.
Nature Communications|May 10, 2020
Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinomaNayoung Kim, Hong Kwan Kim, Kyungjong Lee, et al.
Pageof 34